Asia Pacific Digital Pathology Market- Size, Outlook, Trends and Forecast (2024 – 2032)

Pathology is a field of medical science diagnosis. Digital pathology is rapidly gaining momentum as a proven and essential technology; with specific support for education, tissue-based research, drug development, and the practice of human pathology throughout the world.  It is an innovation committed to the reduction of laboratory expenses, an improvement of operational efficiency, enhanced productivity, and improving treatment decisions and patient care.

Asia Pacific Digital Pathology Market Size & Growth:

The Asia Pacific Digital Pathology market was valued at $0.38 billion in 2019 and is estimated to reach $0.90 billion by 2025, at a CAGR of 12.8% during 2019-2025. The critical factors responsible for the growth of the Asia Pacific digital pathology are rising prevalence of cancer, increasing acceptance of digital pathology to rise lab efficiency, increasing creativities by governments and industry players, ease of consultation enabled by digital pathology. The high cost of digital pathology systems, lack of reimbursement for digital pathology enabled services, and inadequate infrastructure are hampering the growth of the Asia Pacific digital pathology market. Opportunities of the market are disabling the deficiency of pathologists through digital pathology, personalised medicine, the addition of laboratory and digital pathology systems, integration of Laboratory Information Systems (LIS) and Digital Pathology Systems.

Asia Pacific Digital Pathology Market Segments Share:

Asia Pacific digital pathology market is segmented based on the type, product, application, end user and geography. By type, the Asia Pacific digital pathology market is segregated into human pathology, veterinary pathology. Human pathology is the largest market in the Asia Pacific digital pathology market owing to the factors like increasing adoption of the digital pathology to enhance lab efficiency and growing applications of digital pathology. Veterinary pathology is the promising segment tending towards the market growth. By product, the market is segregated into scanners, software, communication systems, storage systems. The software is expected to register the highest growth and is also largest market by product due to the availability of analytical, user-friendly and advanced functions for pathology diagnosis. By application, the market is categorised into teleconsultation, disease diagnosis, drug discovery, training and education. Tele-consultation is the largest market and is expected to register the fastest growth in the market owing to the increasing need for quality, and fast diagnosis have enhanced the utilisation of teleconsultation applications. By Geography the market is classified into China, India, Japan, Australia & New Zealand and Others.

Asia Pacific Digital Pathology Market Trends:

• Indica Labs software solutions provide fast, quantitative evaluation of whole slide tissues using HALO and HALO AI for image analysis and HALO Link to manage images, data, and facilitate collaboration.
• Visiopharm has entered an agreement with HAMAMATSU to sell their portfolio of slide scanners, co-branded as Oncotopix® Scan, for clinical customers in Europe.

Asia Pacific Digital Pathology Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have a complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried out to understand the market more comprehensively.

Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact on altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary critical players in the Asia Pacific Digital Pathology Market are:

• Hamamatsu Photonics, K.K.
• Digipath Co.
• Carl Zeiss AG
• Olympus Corporation
• Yokogawa Electronic Corporation
• Quorum Technologies Inc.

Along with these companies, there were many other companies considered/ cited in the report while analysing the Asia Pacific Digital Pathology market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and stable customer base.